NEW YORK, June 25 - IBM and Spotfire said Monday they would work together to combine Spotfire's software with IBM's back-end information management, data integration, and computing infrastructure.
The companies also said that Aventis would be the first customer to use this combination of Spotfire's DecisionSite analysis platform and IBM's DiscoveryLink integration middleware.
Financial terms for the partnerships were not disclosed.
Under the IBM/Spotfire alliance, Spotfire will optimize its current and future applications for IBM platforms and middleware, including the DB2 database and DiscoveryLink.
Aventis will use DiscoveryLink to manage and integrate data from multiple biological and chemical databases and will use DecisionSite to allow researchers to query those databases and identify new drug targets. The company said it expects this combination of techniques to reduce its drug innovation and approval from 10-15 years to six to nine years.
Spotfire also has partnerships to integrate DecisionSite with products from Micromass and Celera, while IBM has partnerships to integrate DiscoveryLink with products from Micromass, LabBook, and NetGenics.